Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials

IMPORTANCE: Most patients with atrial fibrillation (AF) and coronary artery disease have indications for preventing stroke with oral anticoagulation therapy and preventing myocardial infarction and stent thrombosis with platelet inhibition. OBJECTIVE: To evaluate whether the recently developed ABC (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA Netw Open
Hauptverfasser: Hijazi, Ziad, Oldgren, Jonas, Lindbäck, Johan, Alexander, John H., Alings, Marco, De Caterina, Raffaele, Eikelboom, John W., Ezekowitz, Michael D., Held, Claes, Huber, Kurt, Hylek, Elaine M., Granger, Christopher B., Lopes, Renato D., Vinereanu, Dragos, Siegbahn, Agneta, Wallentin, Lars
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Medical Association 2020
Schlagworte:
Original Investigation
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7495236/
https://ncbi.nlm.nih.gov/pubmed/32936298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2020.15943
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge